RIGL Options $3.38 -2.03% (-0.07) unusual options activity for all expirations

Unusual Flow By Sentiment

Loading...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Top Ranked RIGL Unusual Options Activity

(latest unusual options order flow detected by AI)

Bullish Rigel Pharmaceuticals, Inc. call option contracts are ones that are bought on or above the market's asking price OR put option contracts that are sold on or less than the market's bid price - expecting a move to the upside.
The opposite applies to bearish trades: put options bought on or above the ask OR call options sold at or below the bid price - expecting a move to the downside.



Weighted Average of Option Greeks

Sentiment By Expiry

Order Side Distribution

Loading...

How To Trade RIGL Unusual Options Activity There are many ways to interpret UOA. Some common strategies include looking at the strike prices and comparing them to the current stock price for Rigel Pharmaceuticals, Inc.. A bullish signal can be intrerpreted if you notice a large amount of contracts traded for strikes that are considered out of the money and expiring in the near future. You can then compare the overall volume for that strike to the open interest at the beginning of the day. A larger volume of option contracts traded compared to the open interest would mean this is a new position that is being opened.


Trade History